Bermekimab ile deneysel sistemik skleroz tedavisinin ilk fazı başlıyor

Bermekimab (deneysel bir monoklonal antikor) ile deneysel sistemik skleroz tedavisinin ilk fazı başlıyor…
#Skleroderma #SistemikSkleroz #Repost @scleroderma_txchapter (@get_repost)
・・・
Phase 1 Study of Experimental Systemic Sclerosis Treatment Bermekimab Begins bit.ly/32pFA8G #raredisease #SystemicSclerosis #SystemicScleroderma #SSc #Scleroderma @scleroderma #findacure #curescleroderma #sclerodermaresearch

https://patientworthy.com/2019/10/17/study-experimental-systemic-sclerosis-treatment-bermekimab-begins/?utm_campaign=coschedule&utm_source=twitter&utm_medium=PatientWorthy&utm_content=Phase%201%20Study%20of%20Experimental%20Systemic%20Sclerosis%20Treatment%20Bermekimab%20Begins&fbclid=IwAR0ocl0DvteFQQ4dTIBI1KPF6fM8VnKdzGlOkms9wBRJa94u_m1JeslvJZs